Dade Behring sales grow but profits hit by charge
This article was originally published in Clinica
Dade Behring reported 9% revenue growth in the second quarter as its core chemistry business continued to perform healthily. The company's Dimension analyser family maintained double-digit growth, contrasting with rival Beckman Coulter's disappointing performance in laboratory automation.
You may also be interested in...
Steve Niedelman of the law firm King & Spalding gave manufacturers a few words of advice when prepping their so-called front rooms, where US FDA investigators do the majority of their work during facility inspections. See what he said here.
The latest figures from China's National Health Commission show infections of the new Wuhan coronavirus are continuing to pile up, spreading to more cities in the country and abroad as travel for the Lunar New Year festival goes into high gear. Meanwhile, the Chinese government maintains that the situation is “preventable and controllable.”